Cellyan Biotechnology (HKPD) Current Assets (2024 - 2026)
Cellyan Biotechnology (HKPD) posted quarterly Current Assets of $8.9 million for Q3 2025, little changed year-over-year from $8.9 million in Q3 2024, and up 1.49% quarter-over-quarter from $8.7 million in Q1 2025.
Cellyan Biotechnology (HKPD) Current Assets (2024 - 2026) Analysis & Trends
Cellyan Biotechnology (HKPD) has reported Current Assets for 2 consecutive years, with $8.9 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Current Assets changed 0.25% year-over-year to $8.9 million; the TTM figure through Sep 2025 stood at $8.9 million (changed 0.25% YoY), while the FY2025 annual figure was $8.7 million, up 11.86% from the prior year.
- Current Assets advanced to $8.9 million in Q3 2025 per HKPD's latest filing, from $8.7 million in the prior quarter.
- Across five years, Current Assets topped out at $8.9 million in Q3 2024 and bottomed at $7.8 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.09 Bn | 96.92 Bn | 3.69 Bn | 62.84 Bn |
| 2 | Cencora | 61.60 Bn | 58.79 Bn | 3.61 Bn | 55.34 Bn |
| 3 | Cardinal Health | 54.39 Bn | 49.53 Bn | 2.56 Bn | 38.75 Bn |
| 4 | Henry Schein | 10.02 Bn | 9.86 Bn | 1.10 Bn | 4.60 Bn |
| 5 | Akso Health | 820.26 Mn | 820.04 Mn | - | 189.55 Mn |
| 6 | Edap Tms | 157.99 Mn | 136.45 Mn | 7.34 Mn | 59.02 Mn |
| 7 | Accendra Health | 94.72 Mn | 87.07 Mn | 263.41 Mn | 271.45 Mn |
| 8 | 111 | 30.87 Mn | 109.39 Mn | 18.18 Mn | 269.90 Mn |
| 9 | Cosmos Health | 13.51 Mn | 11.07 Mn | 1.51 Mn | 36.67 Mn |
| 10 | Cellyan Biotechnology | 6.38 Mn | 6.15 Mn | - | 12.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.33 Mn |
| Sep 30, 2025 | 8.86 Mn |
| Mar 31, 2025 | 8.73 Mn |
| Sep 30, 2024 | 8.88 Mn |
| Mar 31, 2024 | 7.80 Mn |